Bio-Gate and Avicanna Create CBD and Micro Silver-BG Skin Care

Jul 6th, 2021
Michele Behrens
Bio-Gate AG
The companies have completed the first phase of development for CBD and Micro Silver BG-based skin care products for global commercialization, starting in North America and Europe.
The companies have completed the first phase of development for CBD and Micro Silver BG-based skin care products for global commercialization, starting in North America and Europe.
Photo 193176904 / Cream © Fukume | Dreamstime.com

Bio-Gate AG announced a licensing and development agreement with Avicanna Inc., a Canadian biopharmaceutical company, to enter the cannabidiol (CBD) market with skin care offerings.

Previously: Bio-Gate MicroSilver BG Proves Effective vs. COVID-19 and Other Viruses

As part of the collaboration, the companies will develop active cosmetic and dermatology products that combine Bio-Gate's MicroSilver BG and CBD, reportedly to deliver synergistic anti-inflammatory and antimicrobial effects. Following the development and initial success of in vitro studies, the products are said to be available for human applications soon.

The products will initially be marketed in Europe and North America. They comply with current EU regulations under a cosmetic designation and will be made available to existing clients of Bio-Gate in Europe and North America.

Avicanna has experience with cannabinoid product development and has commercialized CBD-based skin care products across several markets including North and South America, where the company will lead commercial efforts on the newly developed products as well. Bio-Gate is primarily responsible for sales and commercialization in European markets.

"We are delighted to have Avicanna as our strategic partner as a leading cannabinoid biopharmaceutical company that focuses on cosmetics, skin care and medical-based product applications,” said Marc Lloret-Grau, CEO of Bio-Gate AG. “The collaboration represents a bridge for Bio-Gate to further new technologies. We are once again expanding our product range and thus tapping into a new and extremely high growth market."

“We are thrilled to announce our partnership and achievement of our initial milestones with Bio-Gate, a European bio-medical company with a focus on health technologies like dermatology and skin care as well,” added Aras Azadian, CEO of Avicanna Inc. “We are also optimistic about the potential combination of Avicanna’s intellectual property with that of Bio-Gate’s in addition to the market access and expertise that the two companies can provide in this collaboration."

More in Companies
HYDROSOME LABS TECHNOLOGY ENHANCES ACTIVE INGREDIENT DELIVERY INTO SKIN
Sponsored
HYDROSOME LABS TECHNOLOGY ENHANCES ACTIVE INGREDIENT DELIVERY INTO SKIN
The emerging science of ultra-fine bubbles is shaking up how we think about water. New research shows the power of Hydrosome Labs' technology to enhance cosmetics and step-change precision fermentation.
Jul 16th, 2024
'All participants had a physical count of their hair by a blinded clinician at baseline, 12 and 24 weeks, and the results were also confirmed with blinded photo-grading,' says Jay Small, a trichologist and cofounder of Arey. 'There was a statistical significance between active and placebo groups at both the 12 and 24 week mark.'
Arey's 'The System' Cuts Gray Hair Growth and Boosts Repigmentation by Combatting Canities: New Clinicals
"Vitamin and mineral deficiency, along with oxidative stress from factors like sun and chemical exposure, contribute to hair losing pigment and turning gray," says Jay Small, a trichologist and cofounder of Arey.
Sep 25th, 2024
CEO and Founder of CLOUD, Carolyn Aronson
Founder of It’s a 10 Launches Cloud, a New Mass-Market Hair Care Brand
Luxury hair brand It’s a 10 is launching a new brand, Cloud, in January of 2025. The brand’s hair care products will be available for purchase at 3,500 retail locations across the United States.
Sep 24th, 2024
Trifolium pratense growing in Biomecell
Orius Inaugurates Pilot Facility, Prepares to Industrialize Precision-farmed Botanicals
The launch of this pilot marks the beginning of Orius' industrialization, with plans for the construction of a larger-scale plant to produce botanical raw materials and ingredients.
Sep 20th, 2024
blue sky welcome to NJ highway sign
Sharon Personal Care Establishes NJ Facility Securing U.S. Cosmetic Ingredient Supply
Sharon’s most popular ingredients, which are currently shipped to North America from facilities in Italy and Israel, will be stored at the new warehouse.
Sep 20th, 2024
The new skin microbiome model co-cultivates eight to ten typical skin microbes under conditions allowing all strains of bacteria to proliferate and interact. In the model for acne-prone skin (shown), the culture medium additionally contains artificial skin fat and scales.
Evonik Develops Novel Skin Microbiome Model for Improved Accuracy, Claims Support
Generally, ingredients are screened on individual strains of bacteria but this does not account for the interaction between microorganisms. Evonik’s model co-cultivates 8-10 skin microbes to observe interactions, better supporting microbiome claims.
Sep 18th, 2024
derm skin care concept caucasian woman skin care line general
Beiersdorf, Macro Biologics Partner to Develop Derm/Health Care Antimicrobial Peptides
The joint objective is to create highly effective, safe and sustainable solutions for a variety of applications across Beiersdorf’s brand portfolio, primarily in dermatological skin care and health care.
Sep 13th, 2024
Barbara Lavernos, deputy CEO in charge of research, innovation and technology, L’Oréal Groupe, says, “By mobilizing our respective companies’ research, innovation and manufacturing capabilities and expertise, we are building an end-to-end value chain that we believe has tremendous potential to be a game-changer in bio-based ingredients for beauty.”
L’Oréal Boosts Sustainable Biobased Beauty Goals with Abolis Biotechnologies x Evonik Partnership
"We are thrilled to receive this round of funding which will allow us to take the next step in pushing the boundaries of innovation in biotechnology," says Cyrille Pauthenier, CEO of Abolis Biotechnologies.
Sep 12th, 2024
Among its activities, the company supports the United Nations' 'Be the Change' movement, aligning its initiatives with key sustainable development goals to drive social, environmental and economic progress.
Jojoba Desert Nabs Fair for Life Certification for 5th Consecutive Time
The certification highlights principles such as corporate social responsibility, human rights protection, fair labor conditions, environmental stewardship and ethical sourcing practices.
Sep 10th, 2024
Stephen Lynch, Ph.D., associate vice president of skin care development, L’Oréal USA Research & Innovation
C&T Allēs Welcomes Juror Stephen Lynch, Ph.D., of L'Oreal, in the Eleventh Hour
Building excitement in the final days to submit to the 2025 C&T Allēs, we welcome Stephen Lynch, Ph.D., associate VP of skin care development for L’Oreal USA, to the jury. It's not too late to get in the game — enter now; the deadline is Friday!
Sep 10th, 2024
Under the new research project, the Estée Lauder Companies seeks to decode the neurological connections between fragrance and emotion to drive fragrance product development, packaging innovation, the development of consumer experiences and marketing claims, and more.
The Estée Lauder Companies' New Research Project to Decode the Scent-Emotion Connection
The Estée Lauder Companies seeks to decode the neurological connections between fragrance and emotion to drive fragrance product development, packaging innovation, the development of consumer experiences and marketing claims, and more.
Sep 9th, 2024